OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 147 filers reported holding OCULAR THERAPEUTIX INC in Q1 2024. The put-call ratio across all filers is 2.74 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $678,232 | +9.6% | 74,531 | -46.3% | 0.00% | -20.0% |
| Q4 2023 | $618,740 | +13.1% | 138,731 | -20.3% | 0.01% | 0.0% |
| Q3 2023 | $546,884 | -47.2% | 174,167 | -13.3% | 0.01% | -58.3% |
| Q2 2023 | $1,036,350 | +287775.0% | 200,843 | +193.7% | 0.01% | +100.0% |
| Q1 2023 | $360 | +29.0% | 68,384 | -31.2% | 0.01% | 0.0% |
| Q4 2022 | $279 | -99.9% | 99,338 | +60.8% | 0.01% | 0.0% |
| Q3 2022 | $256,000 | +24.9% | 61,775 | +21.0% | 0.01% | +20.0% |
| Q2 2022 | $205,000 | -28.3% | 51,039 | +24.5% | 0.01% | 0.0% |
| Q4 2021 | $286,000 | -69.8% | 40,987 | -56.7% | 0.01% | -66.7% |
| Q3 2021 | $947,000 | +695.8% | 94,712 | +645.8% | 0.02% | +400.0% |
| Q4 2015 | $119,000 | -67.9% | 12,700 | -28.1% | 0.00% | -72.7% |
| Q2 2015 | $371,000 | – | 17,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
| Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
| DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
| Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
| GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
| Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
| Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
| Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
| Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
| Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |